Biochemical assessment of metabolic associated fatty liver disease
Metabolic-associated fatty liver disease (MAFLD) is defined as fat accumulation in the liver in the presence of metabolic alterations. This disorder is generally asymptomatic and may progress to severe liver disease, which are linked to inflammation and/or fibrosis. MAFLD has a high prevalence (26%)...
Guardado en:
Autores principales: | Guerra-Ruiz Armando R., Casals Gregori, Iruzubieta Paula, Lalana Marta, Leis Alba, López Rosa María, Crespo Javier, Morales-Ruiz Manuel |
---|---|
Formato: | article |
Lenguaje: | EN ES |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4e33d0f9576b45d187bf542aad328304 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Role of oxidative stress and glutathione system in the pathogenesis of nonalcoholic fatty liver disease
por: T. E. Promenasheva, et al.
Publicado: (2014) -
Autophagy: a new target for nonalcoholic fatty liver disease therapy
por: Mao YQ, et al.
Publicado: (2016) -
Measurement and clinical usefulness of bilirubin in liver disease
por: Guerra Ruiz Armando Raúl, et al.
Publicado: (2021) -
Ultrasound Sample Entropy Imaging: A New Approach for Evaluating Hepatic Steatosis and Fibrosis
por: Hsien-Jung Chan, et al.
Publicado: (2021) -
Valoración bioquímica en la enfermedad hepática grasa asociada a la disfunción metabólica
por: Guerra-Ruiz Armando R., et al.
Publicado: (2021)